|

BAL0891 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: TTK-CS-101

Pipeline

Phase 1: 1

Top Sponsors

  • SillaJen, Inc.1

Indications

  • Leukemia Acute Myeloid Leukemia (AML)1
  • TNBC - Triple-Negative Breast Cancer1
  • Advanced Solid Tumor1
  • Gastric Cancer1
  • Breast Cancer1

New Haven, Connecticut1 trial

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

Yale New Haven Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.